publication . Article . 2016

CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICE

Open Access
  • Published: 01 Feb 2016 Journal: Almanac of Clinical Medicine (issn: 2072-0505, Copyright policy)
  • Publisher: Moscow Regional Research and Clinical Institute (MONIKI)
Abstract
The article reviews the use of cardiac glycosides in patients with chronic heart failure, paroxysmal tachyarrhythmia and chronic atrial fibrillation (rate control). According to the recent studies results cardiac glycosides may be substituted by angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, diuretics, calcium antagonists and beta-adrenoceptor blockers in order to decrease the risk of cardiac glycoside toxicity and, in some cases, to improve quality of life and prognosis of the patients.
Persistent Identifiers
Subjects
Medical Subject Headings: cardiovascular system
free text keywords: cardiac glycosides, chronic heart failure, angiotensin-converting enzyme inhibitors, landiolol, Esmolol, medicine.drug, medicine, Angiotensin Receptor Antagonists, Digoxin, business.industry, business, Zofenopril, chemistry.chemical_compound, chemistry, Heart failure, medicine.disease, Cardiology, medicine.medical_specialty, Atrial fibrillation, Internal medicine, Verapamil, Cardiac glycoside, lcsh:Medicine, lcsh:R
Any information missing or wrong?Report an Issue